HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

YCG 063

an angiogenesis inhibitor; structure in first source

Also Known As:

YCG-063; YCG063

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Hydrazines: 379
  - Hydrazones: 500
    - YCG 063: 1
- Nitro Compounds: 66
  - Nitroimidazoles: 565
    - YCG 063: 1
Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Imidazoles: 150
      - Nitroimidazoles: 565
        YCG 063: 1

Experts

1.	Choi, Il-Whan: 1 article (09/2015)
2.	Choi, Jung Sik: 1 article (09/2015)
3.	Choi, Yung Hyun: 1 article (09/2015)
4.	Jang, Won Hee: 1 article (09/2015)
5.	Jung, Won-Kyo: 1 article (09/2015)
6.	Kim, Gi-Young: 1 article (09/2015)
7.	Lee, Dae-Sung: 1 article (09/2015)
8.	Lee, Young-Min: 1 article (09/2015)
9.	Paeng, Sung Hwa: 1 article (09/2015)
10.	Park, Saegwang: 1 article (09/2015)

Related Diseases

1.

Inflammation (Inflammations)

09/01/2015 - "In conclusion, our data indicate that YCG063 may prove to be a potential protective agent against inflammation, possibly through the downregulation of Toll‑like receptor 2 (TLR2) and the AKT-dependent NF-κB activation pathway in PA-LPS-stimulated ARPE-19 cells. "
09/01/2015 - "YCG063 inhibits Pseudomonas aeruginosa LPS-induced inflammation in human retinal pigment epithelial cells through the TLR2-mediated AKT/NF-κB pathway and ROS-independent pathways."

Related Drugs and Biologics

1.	Protective Agents
2.	Retinal Pigments (Pigments, Visual)